RBN-2397, CAS [[2381037-82-5]]

Artikelnummer: BYT-ORB1309170
Artikelname: RBN-2397, CAS [[2381037-82-5]]
Artikelnummer: BYT-ORB1309170
Hersteller Artikelnummer: orb1309170
Alternativnummer: BYT-ORB1309170-1,BYT-ORB1309170-2,BYT-ORB1309170-5,BYT-ORB1309170-10,BYT-ORB1309170-25,BYT-ORB1309170-50,BYT-ORB1309170-100,BYT-ORB1309170-200
Hersteller: Biorbyt
Kategorie: Biochemikalien
Alternative Synonym: cell, carcinoma, advanced, ovarian, NSCLC, metastatic, PARP, PARP7, PARP-7, lung, Inhibitor, inhibit, squamous, solid, RBN 2397, RBN2397, RBN-2397, poly ADP ribose polymerase, tumor
RBN-2397 is a highly potent and selective, orally bioavailable PARP7 inhibitor that competes with NAD+ across multiple species, exhibiting an IC50 below 3 nM. It is a valuable research tool for studying PARP7s role in cancer biology and has demonstrated antitumor activity in both cellular assays and in vivo models.
Molekulargewicht: 523.43
Reinheit: 99.96% (May vary between batches)
CAS Nummer: [2381037-82-5]
Formel: C20H23F6N7O3
Target-Kategorie: PARP
Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.55 mM),DMSO:247 mg/mL (471.89 mM)